• When R&D meets
    the market needs


    TAILOR R&D ACTIVITIES: SATISFY MARKET NEEDS AND SOLVE CUSTOMERS DEMANDS

  • Connection to
    the future


    R&D FOR INNOVATIVE TECHNOLOGIES IN BIOMATERIALS

  • We master
    our potential


    TURNING IDEA INTO INNOVATIVE PRODUCT: A FRONTLINE APPROACH

  • Creative
    instinct


    REAL CONSTANT CHALLENGING R&D

  • A platform technology


    NOT ONLY THE BEST INGREDIENTS, BUT THE IDEAL MIX

  • Raw
    materials


    ACTIVE INGREDIENTS

  • Finished
    products


    SHBF - Moisturize and Protect

  • Finished
    products


    SHB - LOVE FOR SKIN

  • Finished
    products

    SHL - Against Free Radical attack

  • Finished
    products


    SHL10 - LOVE FOR HAIR

  • Partnership
    Projects


    WORK IN-TEAM PROJECT: TO SATISFY PARTNER REQUIREMENTS

  • Find a treasure
    in a molecule


    SIGEA: A PROMISE BY SCIENCE



MISSION

CREATE A NEW FRONTIER IN INNOVATIVE BIOMATERIALS

Innovative approaches obtain molecules with ideal properties.
Our R&D develops novel biomaterials through the combination of bioactive components able to act synergistically
and the final result is a product with exceptional specific properties.
Novelty is our strategy to build our future.

INNOVATION

Key Point

INNOVATION
Through our knowledge and skillness we improve the performances of known molecules and create innovative ingredients

Key Points

Development of New Generation Ingredients

A new frontline technology

Innovation that provides milestone

R&D

Key point

R&D

Our Research and development is focused to find new solutions improving the molecular functionality

Our development starts from the batch scale and ends in the industrial plant

Continuous improvement is our target

We use the best ingredients and the highest safety standards

WORK IN TEAM

Key point

WORK IN TEAM
We have developed an integrated network with different skillness able to:

- optimize processes
- customize products

The final goal is:

- optimization of the product performances
- novel developmental strategy
- design of tailor made products
- preparation of technical and regulatory files

BIOMATERIALS

Key Point

BIOMATERIALS
Key Points

Our outstanding experience in polysaccharides allow us to improve the properties of Glycosaminoglycans, in terms of biological activity and biocompatibility, obtaining different patterns of new and innovative molecular structures

3D network with hydrogels features is obtained with similar technology



R&D

RAW MATERIAL

Key Point

RAW MATERIAL
We develop unique ingredients with superior performances vis à vis the current ingredients

The multipurpose features of our products is able to interact with other ingredients showing unique properties in a broad range of applications

PRODUCT

Key point

PRODUCT

Our functional ingredients make us able to develop proprietary cosmetic formulations and medical devices with unique performances

Our products are the solution for a new generation of devices able to overcome issues not already solved with the traditional approaches

All our products show a synergic activity in an order of magnitude higher than the component mix

PARTNERSHIP PROJECT

Our group suggests the best tailored made answer to your needs

PILOT PRODUCTION

Key Point

PILOT BATCHES
We are able to follow all the developmental steps from the laboratory to industrial scale-up, in compliance to GMP standards



Offer to Your Business the best Quality
Is Our Top Priority

It's why we care first of all our Quality

Sigea is certified ISO 13485:2012

Sigea has adopted a Quality System for the production development and management of medical devices intended for applications in the personal care and wellness.

The compliance with the international standard UNI EN ISO 13485:2012 allows Sigea to demonstrate own ability to provide services able to meet customer requirements, in compliance with the international standards and current laws and regulations.



PLATFORM TECHNOLOGY

The synergy of an ideal mix

IMPROVEMENT

Key Point

We spend our efforts in creating novel products representing the new answers to old issues

SYNERGY

Key point

We create a synergy with a combination between the elements and the result is not the simple sum but the exponential

IDEAL MIX

Key point

THE TARGET IS THE IDEAL MIX

SYMBIOSIS

Key Point

Our approach create links between heterogeneous components that become symbiotic

Platform Technology Movie

The polysaccharide derivatization

Read our brochure on ISSU

  • WE FIND AN HIDDEN TREASURE IN ANY MOLECULE
  • WE HAVE SKILLS AND EXPERTISE TO DO IT
  • WE HAVE SPIRIT OF INNOVATION
  • WE IMPROVE SCIENTIFIC INVESTIGATION AND CREATIVITY FOR GIVING NEW SOLUTIONS


APPLICATION

The TARGET is an ideal mix

The best ingredient characterization (chemical, physical and biological)
combined with the highest safety level in compliance with regulatory requirements.

> Boosting agent
> Long lasting activity
> Combined effect
> Natural radical scavenger
> Antioxidant

Product portfolio

SHB
SHBF
SHL
SHL10

> Intra-articular viscosupplementation
> Dermal filler
> Wound dressing
> Supportive care
> Healthcare
> Mucoadhesion

Product portfolio

SHBFC06
SHLS12
P7045



PRODUCTS

  • SHB

  • P7045

  • SHLS12











SIGEA Mastering&Creating


NAME *

E-mail *

WEBSITE

MESSAGE *

PERSONAL DATA *

I authorize the use of my personal data, pursuant to Legislative Decree. 196 of 30 June 2003

Privacy policy *

I have read the Privacy Policy about the processing of personal data




  • SIGEA SRL
    SEDE della Società 34149 TRIESTE
    Località Padriciano 99
    34149 Trieste ITALY
  • Codice Fiscale e PARTITA IVA 00910640325
  • Società iscritta al Registro delle imprese di TRIESTE al n°40604
  • Capitale Sociale Versato € 16.684,00
  • Phone: + 39 040 3755460
  • Fax: + 39 040 3755461
  • E-mail: sigea@sigea.biz

LUCA STUCCHI Dr. Chem

Phone: +39.040.375.5456
Fax: +39.040.375.5461
E-mail: stucchi@sigea.biz

Privacy Policy

Cookies Policy